Early research (Phase 1)Ended earlyNCT00014560
What this trial is testing
Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Who this might be right for
LeukemiaLymphoma
Dartmouth-Hitchcock Medical Center 3